1. Varga, J, Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117(3): 557–567.
Google Scholar | Crossref | Medline2. Dowson, C, Simpson, N, Duffy, L, et al. Innate immunity in systemic sclerosis. Curr Rheumatol Rep 2017; 19(1): 2.
Google Scholar | Crossref | Medline3. Denton, CP, Khanna, D. Systemic sclerosis. Lancet 2017; 390(10103): 1685–1699.
Google Scholar | Crossref | Medline4. Stafford, DA, Brunet, LJ, Khokha, MK, et al. Cooperative activity of noggin and gremlin 1 in axial skeleton development. Development 2011; 138(5): 1005–1014.
Google Scholar | Crossref | Medline5. Brazil, DP, Church, RH, Surae, S, et al. BMP signalling: agony and antagony in the family. Trends Cell Biol 2015; 25(5): 249–264.
Google Scholar | Crossref | Medline6. McMahon, R, Murphy, M, Clarkson, M, et al. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-β1. J Biol Chem 2000; 275(14): 9901–9904.
Google Scholar | Crossref | Medline7. Li, G, Li, Y, Liu, S, et al. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway. J Cell Biochem 2013; 114(9): 2101–2113.
Google Scholar | Crossref | Medline8. Koli, K, Myllärniemi, M, Vuorinen, K, et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 2006; 169(1): 61–71.
Google Scholar | Crossref | Medline9. Worrell, JC, Walsh, SM, Fabre, A, et al. CXCR3A promotes the secretion of the antifibrotic decoy receptor sIL-13Rα2 by pulmonary fibroblasts. Am J Physiol Cell Physiol 2020; 319(6): C1059–C1069.
Google Scholar | Crossref | Medline10. O’Reilly, S, Ciechomska, M, Cant, R, et al. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem 2014; 289(14): 9952–9960.
Google Scholar | Crossref | Medline11. Duffy, L, Henderson, J, Brown, M, et al. Bone morphogenetic protein antagonist Gremlin-1 Increases Myofibroblast transition in dermal fibroblasts: implications for systemic sclerosis. Front Cell Dev Biol 2021; 9: 681061.
Google Scholar | Crossref | Medline12. Farkas, L, Farkas, D, Gauldie, J, et al. Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol 2011; 44(6): 870–878.
Google Scholar | Crossref | Medline13. Yin, M, Tissari, M, Tamminen, J, et al. Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma. Oncotarget 2017; 8(58): 98280–98297.
Google Scholar | Crossref | Medline14. Ren, J, Smid, M, Iaria, J, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res 2019; 21(1): 109.
Google Scholar | Crossref | Medline15. Mayes, MD, Lacey, JV, Beebe-Dimmer, J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48(8): 2246–2255.
Google Scholar | Crossref | Medline16. Graham, JR, Williams, CM, Yang, Z. MicroRNA-27b targets gremlin 1 to modulate fibrotic responses in pulmonary cells. J Cell Biochem 2014; 115(9): 1539–1548.
Google Scholar | Crossref | Medline17. Heron, M, van Moorsel, CH, Grutters, JC, et al. Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis. Tissue Antigens 2011; 77(2): 112–117.
Google Scholar | Crossref | Medline18. Aoshima, Y, Enomoto, Y, Muto, S, et al. Gremlin-1 for the differential diagnosis of idiopathic pulmonary fibrosis versus other interstitial lung diseases: a clinical and pathophysiological analysis. Lung 2021; 199(3): 289–298.
Google Scholar | Crossref | Medline19. O’Reilly, S, Cant, R, Ciechomska, M, et al. Interleukin-6: a new therapeutic target in systemic sclerosis. Clin Transl Immunol 2013; 2(4): e4–e.
Google Scholar | Crossref | Medline20. Khanna, D, Denton, CP, Jahreis, A, et al. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet 2016; 387(10038): 2630–2640.
Google Scholar | Crossref | Medline21. Cahill, E, Costello, CM, Rowan, SC, et al. Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation 2012; 125(7): 920–930.
Google Scholar | Crossref | Medline